Genome Editing Technologies: Defining a Path to Clinic-Reference-Cited by-同舟云学术

Genome Editing Technologies: Defining a Path to Clinic

Published:2015-05 Issue:5 Volume:23 Page:796-806
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Corrigan-Curay Jacqueline,O'Reilly Marina,Kohn Donald B,Cannon Paula M,Bao Gang,Bushman Frederic D,Carroll Dana,Cathomen Toni,Joung J Keith,Roth David,Sadelain Michel,Scharenberg Andrew M,von Kalle Christof,Zhang Feng,Jambou Robert,Rosenthal Eugene,Hassani Morad,Singh Aparna,Porteus Matthew H

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference44 articles.

1. Genome engineering with targetable nucleases;Carroll;Annu Rev Biochem,2014

2. Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV;Tebas;N Engl J Med,2014

3. ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering;Gaj;Trends Biotechnol,2013

4. ). TAL effectors: customizable proteins for DNA targeting;Bogdanove;Science,2011

5. Efficient design and assembly of custom TALENs using the Golden Gate platform;Cermak;Methods Mol Biol,2015

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances and applications of the CRISPR-Cas system in the gene therapy of blood disorders;Gene;2024-12

2. CRISPR-Cas Genome Editing in Ex Vivo Human Lungs to Rewire the Translational Path of Genome-Targeting Therapeutics;Human Gene Therapy;2024-06-01

3. Interpretable CRISPR/Cas9 off-target activities with mismatches and indels prediction using BERT;Computers in Biology and Medicine;2024-02

4. Regulations of genome edited plants: notes from editors;Global Regulatory Outlook for CRISPRized Plants;2024

5. Advances in CRISPR/Cas systems-based cell and gene therapy;Progress in Molecular Biology and Translational Science;2024